Cargando…
Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies
Ultra-deep next-generation sequencing has emerged in recent years as an important diagnostic tool for the detection and follow-up of tumor burden in most of the known hematopoietic malignancies. Meticulous and high-throughput methods for the lowest possible quantified disease are needed to address t...
Autores principales: | Sánchez, Ricardo, Ayala, Rosa, Martínez-López, Joaquín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600313/ https://www.ncbi.nlm.nih.gov/pubmed/31185671 http://dx.doi.org/10.3390/ijms20112832 |
Ejemplares similares
-
The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies
por: Colmenares, Rafael, et al.
Publicado: (2022) -
P702: APPLICATION OF NEXT GENERATION SEQUENCING (NGS) FOR MINIMAL RESIDUAL DISEASE (MRD) AND CHIMERISM MONITORING IN MYELODYSPLASTIC SYNDROME (MDS) AFTER ALLOGENIC STEM CELL TRANSPLANTATION (ASCT)
por: Zamanillo, Irene, et al.
Publicado: (2023) -
Lessons from next-generation sequencing analysis in hematological malignancies
por: Braggio, E, et al.
Publicado: (2013) -
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
por: Medina, Alejandro, et al.
Publicado: (2020) -
Validation and clinical application of a targeted next-generation sequencing gene panel for solid and hematologic malignancies
por: Prieto-Potin, Iván, et al.
Publicado: (2020)